शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
FAIRCHEMORBSEFAIRCHEM ORGANICS LIMITED· Chemicals & PetrochemicalsHighNeutral
Announced Mon, 27 Jul, 2026 · 12:47 IST

Fairchem Organics Q1 FY26 PAT jumps 8.5x YoY on strong revenue growth

Revenue Growth 20pctPat Growth 25pctResults View source PDFExplain this filing

FAIRCHEMOR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.7%Reaction day
₹770.00
prior close
₹752.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+3.4% vs market
Specialty Chemicals peers, median of 94sector+1.8%+3.0% vs sector

On the reaction day the stock moved 3.4 pts more than Nifty Microcap 250 and 3.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+7.2
10m
+7.2
15m
+7.2
30m
+7.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.7+1.3+3.4+1.8+3.0
Next day
+10.0+0.0+9.9+0.6+9.4
2d
+7.8+0.5+7.3+0.8+6.9
3d
+5.6-0.1+5.7-0.1+5.7
4d
+3.5+1.0+2.5+0.0+3.5
5d
+5.6+2.4+3.2+1.2+4.4
1w
+1.4+4.1-2.7+1.9-0.5
15d
-10.7+5.1-15.8+1.6-12.3
1m
-12.3+5.8-18.2+3.0-15.3
2m
-12.3+4.5-16.9+4.7-17.0
3m
-10.2-2.4-7.8-4.4-5.8
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fairchem Organics reported Q1 FY26 (quarter ended June 30, 2026) revenue of Rs. 176.15 cr, up about 34% YoY from Rs. 131.06 cr. PAT surged to Rs. 10.01 cr versus Rs. 1.17 cr in Q1 FY25, an over 8x jump. PBT rose to Rs. 13.64 cr from Rs. 1.62 cr. EPS stood at Rs. 7.95 versus Rs. 0.90. Auditor B S R and Co gave an unmodified review report. Results approved at the July 27, 2026 board meeting.

Likely market impact

Strong Q1 with sharp profit growth on revenue expansion, suggesting operating leverage and pricing strength.